ZYME Builds 9-Week Cup Base with 31.05 Pivot as Stage 2 Uptrend Holds

Posted on by Eben@CANSLIM Research
ZYME stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 2 (Advancing), as of November 04, 2026 at 00:17 — CANSLIM Research
ZYME is holding a Stage 2 advancing structure above a rising 30-week moving average, with price just 2.7 percent off its 52-week high and 83.5 percent above its yearly low. The market focus is on a 20.2 percent deep, 9-week cup base with a 31.05 pivot, supported by tightening price contractions of 8.8 and 6.6 percent, though volume has not yet dried up enough to confirm a VCP. Overall sentiment is bullish, with seven of eight trend template checks passing and an offensive setup in place ahead of a potential breakout.

ZYME   Daily · data to 2026-11-03 close · 20 SMA 50 SMA 150 SMA
Frozen at publication – this chart does not move. Open live chart on TradingView →

SECTORHealthcareINDUSTRYBiotechnologyStage 2Weinstein stage
Intraday data, US market still open (as of Tue 03 Nov 11:17 ET)Created: Wed 04 Nov 00:17 HKT = 11:17 ET

Inside the Full Report

  • 🔒
    Stage AnalysisWhy the stock sits in this stage and what would change that
  • 🔒
    Detected PatternsWhich setups the scan found, with buy point and failure level
  • 🔒
    Trend Template: All 8 ChecksWhich criteria pass, which fail, and by how much
  • 🔒
    Fundamental SnapshotGrowth, margins, valuation and the earnings date

Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Figures come from the scanned result (as of November 04, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.

Continue Reading

This article is for pass holders.

Already a pass holder? Sign in · Continue with Google

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Related Posts